Advanced search
Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 12
Submit an article Journal homepage
100
Views
2
CrossRef citations to date
0
Altmetric
Rapid Communication

A computer-aided insight into the identification of significant therapeutic flavone as a promising agent for sarcopenic obesity

Sarvesh Sabarathinama Drug Testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, India;b Clinical Trial Unit, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, IndiaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-0792-392XView further author information
ORCID Icon,
Sanjana Satheeshc Department of Biotechnology, Birla Institute of Technology and Science, Dubai Campus, Dubai International Academic City, Dubai, United Arab EmiratesORCID Iconhttps://orcid.org/0000-0002-3628-9673View further author information
ORCID Icon &
Arun Rajad Department of Community Medicine, Sree Balaji Medical College and Hospital, Chennai, IndiaORCID Iconhttps://orcid.org/0000-0002-1662-4462View further author information
ORCID Icon
Pages 2091-2096 | Received 05 Apr 2023, Accepted 28 Jun 2023, Published online: 12 Jul 2023

References

  • Al-Ishaq RK, Mazurakova A, Kubatka P, Büsselberg D. 2022. Flavonoids’ dual benefits in gastrointestinal cancer and diabetes. A potential treatment on the horizon? Cancers (Basel) 14(24):6073. doi:10.3390/cancers14246073.
  • Hussain T, Tan B, Murtaza G, Liu G, Rahu N, Saleem Kalhoro M, Hussain Kalhoro D, Adebowale TO, Usman Mazhar M, Rehman Z, et al. 2020. Flavonoids and type 2 diabetes: evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy. Pharmacol Res. 152:104629. doi:10.1016/j.phrs.2020.104629.
  • Jubaidi FF, Zainalabidin S, Taib IS, Hamid ZA, Budin SB. 2021. The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. IJMS. 22(10):5094. doi:10.3390/ijms22105094.
  • Katiyar C, Gupta A, Kanjilal S, Katiyar S. 2012. Drug discovery from plant sources: an integrated approach. Ayu. 33(1):10–19. doi:10.4103/0974-8520.100295.
  • Kim C, Hwang JK. 2020. Flavonoids: nutraceutical potential for counteracting muscle atrophy. Food Sci Biotechnol. 29(12):1619–1640. doi:10.1007/s10068-020-00816-5.
  • Li X, Geng-Ji J-J, Quan Y-Y, Qi L-M, Sun Q, Huang Q, Jiang H-M, Sun Z-J, Liu H-M, Xie X. 2022. Role of potential bioactive metabolites from traditional Chinese medicine for type 2 diabetes mellitus: an overview [Review]. Front Pharmacol. 13:1023713.
  • Li Y, Liu Y, Tan R, Liu Y. 2022. Effect of flavonoids on skeletal muscle mass, strength and physical performance in middle-aged and older adults with or without Sarcopenia: a meta-analysis of randomized controlled trials. Front Nutr. 9:1013449. doi:10.3389/fnut.2022.1013449.
  • Mierziak J, Kostyn K, Kulma A. 2014. Flavonoids as important molecules of plant interactions with the environment. Molecules. 19(10):16240–16265. doi:10.3390/molecules191016240.
  • Molino S, Dossena M, Buonocore D, Verri M. 2016. Sarcopenic obesity: an appraisal of the current status of knowledge and management in elderly people. J Nutr Health Aging. 20(7):780–788. doi:10.1007/s12603-015-0631-8.
  • Mutha RE, Tatiya AU, Surana SJ. 2021. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Futur J Pharm Sci. 7(1):25. doi:10.1186/s43094-020-00161-8.
  • Sabarathinam S, Rajappan Chandra SK, Satheesh S. 2023. Network pharmacology based pharmacokinetic assessment and evaluation of the therapeutic potential of catechin derivatives as a potential myostatin inhibitor: a special view on Sarcopenic Obesity. Nat Prod Res. :1–5. doi:10.1080/14786419.2023.2191197.
  • Sabarathinam S, Satheesh S, Raja A. 2023. Plant-based medicines in the treatment of cardiometabolic disorders: a special view on sarcopenic obesity. Obesity Med. 41:100497. doi:10.1016/j.obmed.2023.100497.
  • Vijayakumar S, Prabhu S, Rajalakhsmi S, Manogar P. 2016. Review on potential phytocompounds in drug development for Parkinson disease: a pharmacoinformatic approach. Inf Med Unlocked. 5:15–25. doi:10.1016/j.imu.2016.09.002.
  • Xiao J. 2022. Recent advances in dietary flavonoids for management of type 2 diabetes. Curr Opin Food Sci. 44:100806. doi:10.1016/j.cofs.2022.01.002.
  • Zamboni M, Rubele S, Rossi AP. 2019. Sarcopenia and obesity. Curr Opin Clin Nutr Metab Care. 22(1):13–19. doi:10.1097/MCO.0000000000000519.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.